⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14737805 | 0.80 | — | — | |
| SCHEMBL1743181 | 0.78 | — | — | |
| SCHEMBL3193648 | 0.78 | — | — | |
| SCHEMBL27710914 | 0.74 | — | — | |
| SCHEMBL8984531 | 0.71 | TDP1 (0.48) | — | |
| SCHEMBL18902557 | 0.71 | LMNA (0.41) | — | |
| SCHEMBL2735769 | 0.69 | — | — | |
| SCHEMBL28052414 | 0.69 | — | — | |
| SCHEMBL9542105 | 0.69 | LMNA (0.47) | — | |
| SCHEMBL8647708 | 0.69 | LMNA (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4107529-A1 | METHODS FOR THE QUANTIFICATION OF GLYCOPROTEINS | Genmab B.V. (NL) | 2022-12-28 | — | — | EP | claimed |
| US-10287616-B2 | Label free biosensors, gram-negative bacteria detection, and real-time and end point determination of antibiotic effects | OAKLAND UNIVERSITY (US) | 2019-05-14 | — | — | US | claimed |
| US-20160355866-A1 | LABEL FREE BIOSENSORS, GRAM-NEGATIVE BACTERIA DETECTION, AND REAL-TIME AND END POINT DETERMINATION OF ANTIBIOTIC EFFECTS | OAKLAND UNIVERSITY | 2016-12-08 | — | — | US | claimed |
| EP-2340305-A1 | CELL LINES AND PROTEINS WITH VARIANT GLYCOSYLATION PATTERN | Eureka Therapeutics, Inc. (US) | 2011-07-06 | — | — | EP | claimed |
| WO-2010036443-A1 | CELL LINES AND PROTEINS WITH VARIANT GLYCOSYLATION PATTERN | Eureka Therapeutics, Inc. (US) | 2010-04-01 | — | — | WO | claimed |
| WO-2024112884-A1 | BIOSYNTHESIS OF DIHYDROCHALCONES AND DIHYDROSTILBENOIDS | CONAGEN INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| EP-4298237-A1 | SINGLE CELL GLYCAN PROFILING | 10X Genomics, Inc. (US) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023205659-A2 | GLYCOENGINEERED ANTIBODIES | AUGMENT BIOLOGICS, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| EP-3917558-A1 | GLUCOCEREBROSIDASE POLYPEPTIDES | Oxyrane UK Limited (GB) | 2021-12-08 | — | — | EP | disclosed |
| EP-3781688-A1 | TNF-TARGETING APTAMERS AND USES THEREOF FOR TREATMENT OR DIAGNOSING TNF-RELATED INFLAMMATORY DISEASES | Academia Sinica (TW) | 2021-02-24 | — | — | EP | disclosed |
| WO-2020157248-A1 | GLUCOCEREBROSIDASE POLYPEPTIDES | OXYRANE UK LTD (GB) | 2020-08-06 | — | — | WO | disclosed |
| WO-2019203904-A1 | TNF-TARGETING APTAMERS AND USES THEREOF FOR TREATMENT OR DIAGNOSING TNF-RELATED INFLAMMATORY DISEASES | ACADEMIA SINICA (TW) | 2019-10-24 | — | — | WO | disclosed |
| EP-1187636-A1 | INJECTABLE HYALURONATE-SULFATED POLYSACCHARIDE CONJUGATES | Orquest, Inc. (US) | 2002-03-20 | — | — | EP | disclosed |
| EP-1178816-A2 | MATERIALS FOR SOFT TISSUE AUGMENTATION AND METHODS OF MAKING AND USING SAME | Orentreich Foundation for the Advancement of Science, Inc. (US) | 2002-02-13 | — | — | EP | disclosed |
| WO-2000078356-A1 | INJECTABLE HYALURONATE-SULFATED POLYSACCHARIDE CONJUGATES | ORQUEST, INC. (US) | 2000-12-28 | — | — | WO | disclosed |
| WO-2000067774-A2 | MATERIALS FOR SOFT TISSUE AUGMENTATION AND METHODS OF MAKING AND USING SAME | ORENTREICH FOUNDATION FOR THE ADVANCEMENT OF SCIENCE, INC. (US) | 2000-11-16 | — | — | WO | disclosed |
| EP-0465481-A1 | NEW SUBSTITUTED ALKYLAMIDE DERIVATIVES OF TEICOPLANIN. | LEPETIT SPA (IT) | 1992-01-15 | — | — | EP | disclosed |
| EP-0437604-A4 | RECOMBINANT POXVIRUS AND STREPTOCOCCAL M PROTEIN VACCINE | — | 1991-11-13 | — | — | EP | disclosed |
| EP-0437604-A1 | RECOMBINANT POXVIRUS AND STREPTOCOCCAL M PROTEIN VACCINE | THE ROCKEFELLER UNIVERSITY (US) | 1991-07-24 | — | — | EP | disclosed |
| WO-1990011300-A1 | NEW SUBSTITUTED ALKYLAMIDE DERIVATIVES OF TEICOPLANIN | GRUPPO LEPETIT S.P.A. (IT) | 1990-10-04 | — | — | WO | disclosed |